Budget Battles
-
Blowout Job Growth Points to ‘Mother of All Soft Landings’
-
Cost Estimates Soar for Hurricane Helene
-
Feds Warn Emergency Funds Running Low as Biden Deploys Troops to Southeast
-
Speaker Johnson Outlines 5-Point Republican Agenda for 2025
-
Biden May Call Congress Back to Pass Hurricane Relief
-
Harris Tries to Flip Trump’s Biggest Advantages
-
US Economy Stronger Than Previously Thought
-
5 Quick Takeaways From the Vice Presidential Debate
Tuesday night’s vice-presidential debate elicited some words that have rarely been used to describe U.S. political discourse in recent years: civil, cordial, nice. Sen. JD Vance and Gov. Tim Walz...
-
Voters Want to Hear More From Harris and Trump on Healthcare: Poll
Two-thirds of American adults say that healthcare issues are getting short shrift in the presidential campaign, according to a new poll from Gallup and West Health. Majorities across the political...
-
What Harris and Trump Said on Taxes and Healthcare at the Debate
Last night’s debate between Vice President Kamala Harris and former President Donald Trump likely won’t be remembered for fiscal policy points as much as, say, discussion about abortion, immigration...
-
Biden Cap on Drug Costs Will Save Millions an Average $1,500 Next Year: Analysis
The new cap on out-of-pocket prescription drug costs enacted as part of the 2022 Inflation Reduction Act will save more than 3 million Medicare beneficiaries an average of $1,500 next year, according...
-
Harris Targets Middle-Class Affordability in New Economic Agenda
By Michael Rainey and Yuval RosenbergVice President Kamala Harris on Friday outlined the economic policies she aims to pursue in the first 100 days of her administration, including proposals to subsidize homebuyers, reward families with...
-
Biden, Harris Celebrate Medicare Drug Price Cuts That Will Save Billions
By Michael RaineyAppearing together for the first time since she replaced him atop the Democratic ticket, President Joe Biden and Vice President Kamala Harris on Thursday celebrated a milestone in the new program...
-
Childhood Vaccinations Have Delivered Huge Benefits Over 3 Decades: CDC
Routine childhood vaccinations have benefitted the public immensely over the past three decades, in both economic and health terms, according to a new analysis by the Centers for Disease Control and...
-
National Uninsured Rate Rises in 2024
By Michael RaineyAfter hitting a record low of 7.2% last year, the percentage of the U.S. population without health insurance rose to 8.2% in the first quarter of 2024, according to new data from the Centers for...
-
Powerful Middlemen Are Jacking Up Drug Prices: FTC
By Michael RaineyThe middlemen who buy and sell prescription drugs throughout the U.S. healthcare system are inflating prices for consumers, according to an interim report released Tuesday by the Federal Trade...
-
Insurers Bilk Medicare for $50 Billion to Treat Fictitious Illnesses
By Michael RaineyPrivate insurance firms running Medicare Advantage programs have been overcharging the federal government billions of dollars by making patients look sicker than they really are, according to a...
-
Biden Administration to Reduce Prices on Dozens of Prescription Drugs in Medicare
By Michael RaineyThe Biden administration announced Wednesday that it will reduce the prices of 64 prescription drugs for Medicare enrollees as part of its effort to combat soaring pharmaceutical costs. The price...
-
CBO Raises Its 2024 Deficit Forecast 27% to Nearly $2 Trillion
By Michael RaineyThe federal budget deficit will reach an estimated $1.9 trillion in fiscal year 2024, according to an updated outlook released by the Congressional Budget Office Tuesday. The new projection...
-
Healthcare Spending Will Account for Almost 20% of US Economy by 2032: CMS
U.S. healthcare spending grew faster than the economy overall last year and is expected to continue doing so through 2032 as it climbs to nearly one-fifth of gross domestic product, according to a...
-
1 in 8 US Adults Has Taken Ozempic or Other GLP-1 Drug: Survey
About 12% of American adults say they have used one of the increasingly popular weight loss and diabetes drugs known as GLP-1s, and 6% say they are currently taking such a drug, according to a new...
-
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead: Report
Eight drug companies that make the 10 medications whose prices are currently being negotiated by Medicare spent billions more last year on stock buybacks, dividends, marketing and administrative...